THE RATIONALE FOR A DIFFERENTIATED APPROACH TO THE TREATMENT OF RECURRENT ENDOMETRIAL HYPERPLASIA IN PERIMENOPAUSAL WOMEN
We performed a comprehensive clinical and laboratory study of 140 patients aged 45-55 with recurrent endometrial hyperplasia. The study of the hormonal status of women revealed ovarian hyperestrogeny thus enabling the surgeon to select the appropriate treatment for endometrial hyperplasia in perimenopausal women.